Case 31-2021: A 21-Year-Old Man with Sore Throat, Epistaxis, and Oropharyngeal Petechiae [language] = "en-us"

Di |2021-10-14T23:00:00+02:00Ottobre 14th, 2021|Categorie: Coronavirus NEJM|

Presentation of Case. Dr. Philippe-Antoine Bilodeau (Medicine): A 21-year-old man presented to this hospital with a sore throat, epistaxis, and petechiae of the oropharynx. One week before the current presentation, blood-filled blisters developed insid...

Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion [language] = "en-us"

Di |2021-10-14T23:00:00+02:00Ottobre 14th, 2021|Categorie: Coronavirus NEJM|

To the Editor: Pregnant persons are at risk for severe coronavirus disease 2019 (Covid-19), and infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy is associated with increased risks of preterm birth and other a...

Data in Crisis — Rethinking Disaster Preparedness in the United States [language] = "en-us"

Di |2021-10-14T23:00:00+02:00Ottobre 14th, 2021|Categorie: Coronavirus NEJM|

In 2017, Hurricane Maria’s devastating impact in Puerto Rico exposed significant flaws in the U.S. medical and public health response to natural disasters. The majority of the nearly 3000 excess deaths caused by the hurricane were attributable not to i...

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers [language] = "en-us"

Di |2021-10-14T23:00:00+02:00Ottobre 14th, 2021|Categorie: Coronavirus NEJM|

Since its rollout in late 2020 in Israel, the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) has been highly effective in preventing clinically significant coronavirus disease 2019 (Covid-19) caused by severe acute respiratory syndrome coronavirus 2 ...